drugset / Trial / NCT01605773
Effect of Repaglinide on Postprandial Lipemia in Type 2 Diabetes
RandomizedParallel-groupOpen-labelTreatment
Summary
This trial is conducted in the United States of America (USA). The aim of this trial is to compare the effect of repaglinide on postprandial lipemia in subjects with type 2 diabetes.
Timeline
- Start
- 2001-11-08
- Primary completion
- 2003-03-13
- Completion
- 2003-03-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Glyburide | Small molecule | — | — |
| Subject | Repaglinide | Small molecule | — | — |